Repurposing old drugs to chemoprevention: the case of metformin.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Seminars in Oncology

• Publication date

  2016-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1053/j.seminoncol.2015.09.009PMID 26970131PMCID PMC4789107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lack of Effect of Metformin on Mammary Carcinogenesis in Nondiabetic Rat and Mouse Models

  2015cited by this paper
• Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus.

  2015cited by this paper
• Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies

  2015cited by this paper
• Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells

  2014cited by this paper
• Effects of metformin on endometrial cancer cell growth in vivo: A preoperative prospective trial

  2014cited by this paper
• Effect of metformin on breast cancer metabolism

  2014cited by this paper
• Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer

  2014cited by this paper
• Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders

  2014cited by this paper
• Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer

  2014cited by this paper
• Repurposing of Metformin and Aspirin by Targeting AMPK-mTOR and Inflammation for Pancreatic Cancer Prevention and Treatment

  2014cited by this paper
• A pilot ‘window of opportunity’ neoadjuvant study of metformin in localised prostate cancer

  2014cited by this paper
• OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin

  2014cited by this paper
• Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?

  2013influential reference
• Metformin Inhibits Skin Tumor Promotion in Overweight and Obese Mice

  2013cited by this paper
• Metformin targets c-MYC oncogene to prevent prostate cancer.

  2013cited by this paper
• Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review

  2013cited by this paper
• Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice.

  2013cited by this paper
• Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.

  2013cited by this paper
• Potential applications for biguanides in oncology.

  2013cited by this paper
• Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis

  2012cited by this paper
• Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.

  2012cited by this paper
• Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis.

  2012cited by this paper
• Metformin and the Risk of Cancer

  2012cited by this paper
• Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth

  2012cited by this paper
• Metformin Prevents the Development of Oral Squamous Cell Carcinomas from Carcinogen-Induced Premalignant Lesions

  2012cited by this paper
• Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.

  2012cited by this paper
• Investigating metformin for cancer prevention and treatment: the end of the beginning.

  2012cited by this paper
• Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis

  2012cited by this paper
• Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage

  2012cited by this paper
• Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

  2012cited by this paper
• Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.

  2012cited by this paper
• A phase III randomized trial of metformin versus placebo on recurrence and survival in early-stage breast cancer (BC) (NCIC Clinical Trials Group MA.32).

  2011cited by this paper
• Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes

  2011cited by this paper
• Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial

  2011cited by this paper
• If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice

  2011cited by this paper
• Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells

  2011cited by this paper
• Promoter-specific effects of metformin on aromatase transcript expression.

  2011cited by this paper
• Metformin as an energy restriction mimetic agent for breast cancer prevention

  2011influential reference
• Diabetes and Cancer

  2010cited by this paper
• Metformin: A Therapeutic Opportunity in Breast Cancer

  2010influential reference
• Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis

  2010influential reference
• Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.

  2010cited by this paper
• Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial

  2010cited by this paper
• Metformin suppresses azoxymethane‐induced colorectal aberrant crypt foci by activating AMP‐activated protein kinase

  2010cited by this paper
• Metformin and Other Biguanides in Oncology: Advancing the Research Agenda

  2010influential reference
• Chemoprevention Meets Glucose Control

  2010cited by this paper
• Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice

  2010cited by this paper
• Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

  2010cited by this paper
• Metformin in chemically-induced mammary carcinogenesis in rats.

  2009cited by this paper
• The LKB1–AMPK pathway: metabolism and growth control in tumour suppression

  2009cited by this paper
• Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.

  2009cited by this paper
• Immunology: A metabolic switch to memory

  2009cited by this paper
• Metformin slows down aging and extends life span of female SHR mice

  2008cited by this paper
• AMPK phosphorylation of raptor mediates a metabolic checkpoint.

  2008cited by this paper
• The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

  2008cited by this paper
• Metformin suppresses intestinal polyp growth in ApcMin/+ mice

  2008cited by this paper
• Insulin-lowering effects of metformin in women with early breast cancer.

  2008cited by this paper
• Neither LKB1 nor AMPK are the direct targets of metformin.

  2006cited by this paper
• The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin

  2005influential reference
• Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.

  2005cited by this paper
• Upstream and downstream of mTOR.

  2004influential reference
• Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

  2002cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism.

  2002cited by this paper
• Prevention of pancreatic cancer induction in hamsters by metformin.

  2001cited by this paper
• Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

  2000cited by this paper
• Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0982 Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status

  year unknowncited by this paper

• Re/99mTc Tricarbonyl Phenformin Complexes Targeting Mitochondria as Pancreatic Cancer Theranostics.

  2025cites this paper
• Synergistic anticancer activity of Sulphoraphane and Teriflunomide co loaded lignin nanoparticles against triple negative breast cancer: Targeted nanoparticle delivery and drug repurposing

  2024cites this paper
• An Updated Review on Repurposing of Metformin

  2024cites this paper
• The Role of Metformin as Chemopreventive Strategies for Hepatocellular Carcinoma

  2023cites this paper
• Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review

  2023cites this paper
• Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers

  2023cites this paper
• Does memantine show chemopreventive effect against mice 4T1 breast tumor model?

  2022cites this paper
• EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells

  2022cites this paper
• Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma

  2021cites this paper
• Influence of YES1 Kinase and Tyrosine Phosphorylation on the Activity of OCT1

  2021cites this paper
• Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights

  2021cites this paper
• Metformin as a New Perspective in the Medical Management of Breast Fibroadenoma; A Randomized Clinical Trial Study

  2021cites this paper
• Dudrick research symposium: expanding the boundaries of cancer care through nutritional support.

  2021cites this paper
• Metformin Potentiates the Anticancer Effect of Everolimus on Cervical Cancer In Vitro and In Vivo

  2021cites this paper
• Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial

  2021cites this paper
• Modern computational intelligence based drug repurposing for diabetes epidemic.

  2021cites this paper
• Comparative assessment of in vitro BBB tight junction integrity following exposure to cigarette smoke and e-cigarette vapor: a quantitative evaluation of the protective effects of metformin using small-molecular-weight paracellular markers

  2021cites this paper
• Use of metformin and risk of breast and colorectal cancer.

  2020cites this paper
• Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin

  2020influential citation
• Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells

  2020cites this paper
• Competitive glucose metabolism as a target to boost bladder cancer immunotherapy

  2020cites this paper
• Web-based tools for drug repurposing: successful examples of collaborative research.

  2020cites this paper
• Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer

  2020cites this paper
• FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling.

  2020cites this paper
• Emerging roles of the MAGE protein family in stress response pathways

  2020cites this paper
• Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.

  2020cites this paper
• Chemoprevention in Oral Cancer

  2020cites this paper
• Epigenetics, Public Health, Lifestyle, and Chemoprevention

  2019cites this paper
• Nutraceuticals and "Repurposed" Drugs of Phytochemical Origin in Prevention and Interception of Chronic Degenerative Diseases and Cancer.

  2019cites this paper
• Metformin prevents cell tumorigenesis through autophagy-related cell death

  2019cites this paper
• The Many Faces of Obesity and Its Influence on Breast Cancer Risk

  2019cites this paper
• Lung Cancer Prevention

  2019cites this paper
• Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway

  2019cites this paper
• Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead

  2018cites this paper
• Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis

  2018cites this paper
• Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment

  2018cites this paper
• Cancer Chemoprevention: Classic and Epigenetic Mechanisms Inhibiting Tumorigenesis. What Have We Learned So Far?

  2018cites this paper
• Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance

  2018cites this paper
• What the oncologist can learn from diabetes studies: Epidemiology, prevention, management, cure.

  2018cites this paper
• Downregulation of Rab27A contributes to metformin-induced suppression of breast cancer stem cells

  2017cites this paper
• Diabetes drugs and the incidence of solid cancers: a survey of the current evidence

  2017influential citation
• Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice

  2017cites this paper
• Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

  2017cites this paper
• Mitochondria-targeted metformins: anti-tumour and redox signalling mechanisms

  2017cites this paper
• Results from 11C-metformin-PET scans, tissue analysis and cellular drug-sensitivity assays questions the view that biguanides affects tumor respiration directly

  2017cites this paper
• Targeting aerobic glycolysis in breast and ovarian cancer

  2017influential citation
• Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users

  2017cites this paper
• Repurposing metformin for the prevention of cancer and cancer recurrence

  2017cites this paper
• Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?

  2017cites this paper
• Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies

  2017cites this paper
• Association between Dietary Energy Density and Obesity-Associated Cancer: Results from the Women's Health Initiative.

  2017cites this paper
• Design of efficient computational workflows for in silico drug repurposing.

  2017cites this paper
• Connecting (T)issues: How Research in Fascia Biology Can Impact Integrative Oncology.

  2016cites this paper
• Cancer Prevention and Interception: A New Era for Chemopreventive Approaches

  2016cites this paper
• Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival

  2016cites this paper
• Chemoprevention : Using Drugs and Nutrients to Decrease Cancer Risk

  2016cites this paper
• Cancer Prevention: Lessons Learned and Future Directions.

  2016cites this paper